基础医学与临床 ›› 2013, Vol. 33 ›› Issue (4): 406-411.

• 研究论文 • 上一篇    下一篇

HCV核心蛋白抑制SFRP1基因启动子活性

权会琴,聂丹,周帆,陈林林,陈庆美,单晓亮,谢青,唐霓   

  1. 重庆医科大学感染性疾病分子生物学教育部重点实验室
  • 收稿日期:2012-08-29 修回日期:2012-12-05 出版日期:2013-04-05 发布日期:2013-03-15
  • 通讯作者: 唐霓 E-mail:nitang809@hotmail.com
  • 基金资助:
    胞质NPM突变蛋白调控TRAF6介导的AKT泛素化激活在急性髓系白血病中的作用

HCV Core protein inhibits SFRP1 gene promoter activity

  • Received:2012-08-29 Revised:2012-12-05 Online:2013-04-05 Published:2013-03-15

摘要: 目的 探讨HCV 核心蛋白对Wnt信号通路抑制分子SFRP1启动子活性的影响。方法 以人肝癌细胞系Huh7基因组为模板,扩增SFRP1启动子区不同片段(-407~-27bp, -837~-27bp, -1202~-27bp, -1619~-27bp, -2029~-27bp),以pGL3-Basic为载体分别构建SFRP1启动子区截短报告质粒。将构建好的质粒与pRL-TK共转染HEK293细胞,确定启动子区活性最强区域;分别用编码HCV 核心蛋白的腺病毒或GFP对照腺病毒感染已转染重组报告质粒的SK-Hep1细胞,观察AdCore对SFRP1启动子活性的调控作用。结果 SFRP1启动子区域-407~-27bp片段活性最强;与pGL3-Basic对照组相比较,相对荧光素酶活性增加了37.31±4.45倍(P<0.01),pGL3-S2~S5的活性分别增加了28.74±2.47、13.56±2.52、12.97±0.87和8.29±0.09倍(P<0.01);HCV Core蛋白能够抑制SFRP1基因启动子区活性,其对pGL3-S1的抑制作用最强,与GFP对照组相比较,抑制率为63.8%±1.0% (P<0.01)。结论 HCV核心蛋白通过抑制SFRP1启动子区活性下调SFRP1基因的表达,可能参与Wnt/β-catenin信号通路的活化,并与原发性肝癌的发生密切相关。

关键词: 关键词:SFRP1, 启动子, 荧光素酶报告基因载体, HCV Core

Abstract: Objective To investigate the effects of HCV Core on SFRP1 gene promoter activity. Methods Different lengths of the 5’-flanking region of SFRP1 promoter were amplified from hepatoma cell line Huh7 genome DNA by PCR methods. The products were cloned into pGL3-Basic vector. The recombinant reporter plasmids and control plasmid pRL-TK were cotransfected into HEK293 to determine the strongest activity area of SFRP1 promoter. To examine whether HCV Core could inhibit SFRP1 promoter activity, hepatoma cell line SK-Hep1 were transfected with reporter plasmids and then infected with AdCore or AdGFP control. The promoter activity was measured by luciferase activity. Results The strongest activity area of SFRP1 promoter was -407~-27nt . Compared with pGL3-Basic negative control, the relative luciferase activity increased by 37.31±4.45 folds (P<0.01). And other reporters(pGL3-S2~S5) increased by28.74±2.47, 13.56±2.52, 12.97±0.87and 8.29±0.09 folds respectively(P<0.01). HCV Core protein could inhibit SFRP1 promoter activity. The inhibitory effect on pGL3-S1 was the strongest, with inhibitory rate 63.8%±1.0% (P<0.01). Conclusions HCV Core protein inhibits SFRP1 promoter activity, resulting in down-regulation of SFRP1 mRNA expression level, thus participating in HCC carcinogenesis.

Key words: Key words:SFRP1, promoter, luciferase reporter vector, HCV Core

中图分类号: